{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
21 CFR 358B
(2009)
Source URL:
First approved in 2009
Source:
21 CFR 358B
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
UK NHS:Self-emulsifying glyceryl monostearate
Source URL:
First approved in 2008
Source:
21 CFR 348
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M032
(2018)
Source URL:
First approved in 2008
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M006
(2008)
Source URL:
First approved in 2008
Source:
M006
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT04560283: Phase 4 Interventional Completed Vagina; Anomaly
(2016)
Source URL:
First approved in 2008
Source:
UREA by SOLUTECH PHARMACEUTICALS LLC
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
First approved in 2008
Source:
BP Cleansing Wash by Acella Pharmaceuticals, LLC
Source URL:
Class:
MIXTURE
Conditions:
Disodium oleic monoethanolamine sulfosuccinate is excipient used in pharmaceutical and cosmetic as preservative and as non-toxic and non-irritating capsulated laundry detergent.
Status:
Possibly Marketed Outside US
Source:
21 CFR 333
(2010)
Source URL:
First approved in 2008
Source:
21 CFR 333
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M005
(2008)
Source URL:
First approved in 2008
Source:
M005
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 358H
(2008)
Source URL:
First approved in 2008
Source:
21 CFR 358H
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT01230840: Phase 4 Interventional Completed Colonic Inertia
(2009)
Source URL:
First approved in 2008
Source:
NDA022107
Source URL:
Class:
MIXTURE